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Abstract 
Exercise can exert anti-inflammatory effects in an intensity-dependent manner; 
however, the mechanisms mediating these effects are continually being established. 
Programme Death Receptor-1 (PD-1) is a membrane bound receptor that maintains immune 
tolerance by dampening immune cell interactions, such as those mediated by cytotoxic T-cell 
lymphocytes (CD8+). The aim of this study was to characterise sub-populations of CD8+ T-
cells with regards to their expression of PD-1 before and immediately after exercise. 
Interleukin (IL)-6, soluble PD-1 (sPD-1) and its ligand (sPD-L1) were also quantified in 
plasma. Eight individuals (mean ± SD: age 29 ± 5 years; BMI 24.2 ± 3.4 kg.m2; O2max 44.5 
± 6.4 ml·kg-1·min-1) undertook two time and energy-matched cycling bouts in a 
counterbalanced study design: one of moderate intensity (MOD) and a bout of high intensity 
interval exercise (HIIE). Both MOD and HIIE increased the number, but not the proportion of 
circulating CD8+ PD-1+ cells, with no differences between trials. Within the CD8+ PD-1+ 
pool, the expression of PD-1 increased on central memory cells following HIIE only (fold 
change: MOD 1.0 vs HIIE +1.4), as well the concentration of CD8+PD-1+ memory cells 
within the circulation (cells/uL: MOD -0.4 vs HIIE +5.8). This response composed a very 
small part of the exercise-induced CD8+ lymphocytosis (Pre-Ex: 0.38% to Post-Ex: 0.69%; 
p>.05). sPD-L1 and IL-6 concentration increased in tandem following MOD and HIIE 
(r=0.57; P=0.021), with a reciprocal decline in sPD-1 observed. The current data demonstrate 
that PD-1+ CD8+ lymphocytes were mobilised following both MOD and HIIE. Both the 
number of central memory CD8+ T-cells expressing PD-1 and the expression level on these 
cells were increased following HIIE only. This intensity-dependent phenotypic response, in 
conjunction with increased circulatory sPD-L1 may represent an aspect of the anti-
inflammatory response to exercise and warrants further investigation. 
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Introduction 
Regular exercise can lower systemic inflammation in both healthy and clinical 
populations (Hamer et al., 2014, 2012). The cumulative impact of acute inflammatory 
responses that follow individual exercise bouts is believed to be a major stimulus for creating 
this anti-inflammatory environment, which appears more marked at higher exercise 
intensities (Wang et al., 2012). The mechanisms underpinning these effects are primarily 
attributed to: 1) increased release of myokines from skeletal muscle (e.g. IL-6), 2) phenotypic 
shifts in cell composition (blood monocytes and adipose tissue-resident macrophages) and 3) 
a reduction in the expression of membrane-bound immune receptors that govern immune cell 
activity, migration and inflammatory cytokine production (Gleeson et al., 2011). The 
independent contribution of these factors is far from clear and a myriad of other mechanisms 
likely contribute. For example, programmed-death receptor-1 (PD-1) is an immune 
checkpoint receptor with an established role in regulating circulating inflammatory signals 
(Coles et al., 2014) but is yet to be extensively characterised following acute exercise or 
periods of exercise training.  
PD-1 is a membrane-bound receptor primarily expressed on lymphoid cells that 
provides a ‘brake’ or checkpoint for the immune system (Francisco et al., 2010). PD-1 
interacts specifically with its co-stimulatory ligands, PD-Ligand 1 (PD-L1) and 2 (PD-L2), 
which are ubiquitously expressed. These ligand-receptor interactions result in reduced 
immune cell activity and thus provide an anti-inflammatory environment that is critical for 
the maintenance of immunological homeostasis. It is now well established that aberrant 
expression of PD-1 can dramatically affect immune function and health (Bartosińska et al., 
2018; Granados et al., 2017; Iijima et al., 2017; Ilie et al., 2016; Li et al., 2014; Lu et al., 
2017; Novák et al., 2015). High expression of PD-1 on certain immune cells (e.g. cytotoxic 
T-cells (CD8+)) is known to severely suppress immune function in numerous blood and 
tissue cancers (Ilie et al., 2016; Lu et al., 2017; Novák et al., 2015). Conversely, reduced 
expression of PD-1 has been documented on CD8+ T-cells from patients with autoimmune 
diseases, such as type-1 diabetes (Granados et al., 2017; Iijima et al., 2017), rheumatoid 
arthritis (Li et al., 2014) and Psoriasis (Bartosińska et al., 2018), driving autoimmunity. These 
studies underpin the central role that PD-1 has in regulating immunological homeostasis, and 
yet, alterations in PD-1 expression have only recently been explored for the first time in the 
context of exercise (Gustafson et al., 2017). 
Gustafson et al (2017) reported that a single session of maximal cycling marginally 
increased the blood composition of PD-1+ T-cells within CD4+ (+ 3.15%) and CD8+ (+ 
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5.53%) subsets (Gustafson et al., 2017). It is well documented that the influx of lymphocytes 
into the circulation during exercise is largely driven by CD8+, rather than CD4+ T-cells 
(Turner et al., 2016), and is dependent on the intensity of the bout (Campbell et al., 2009). 
The composition of this CD8+ T-cell pool is markedly altered to favour increased immune 
surveillance for antigen-presentation at secondary lymphoid organs and inflamed tissues 
(Dhabhar et al., 2012). PD-1 is primarily expressed on memory cells (Claireaux et al., 2018) 
and functions to limit the inflammatory response by increasing apoptosis of antigen-specific 
effector T-cells (Francisco et al., 2010); however, how antigen-specific frequencies of CD8+ 
T-cells expressing PD-1 change following exercise bouts of different intensities is currently 
unknown. Further to the membrane-bound forms of PD-1 and PD-L1, soluble (s) PD-1 and 
sPD-L1 are detectable within the extracellular environment of blood (Chen et al., 2018; Wei 
et al., 2018), but have yet to be explored in the context of exercise, despite their role in 
modulating T-cell activity (Kuipers et al., 2006; Song et al., 2011).  
Our collective understanding of both membrane and soluble PD-1 in the context of 
exercise and immunity is currently lacking, particularly regarding how exercise alters the 
specific memory phenotype of T-cells expressing PD-1, their physiological relevance in 
blood (i.e. number of cells expressing PD-1) and relationships to sPD-1 and sPD-L1. 
Characterisation of these responses could provide important insight into the anti-
inflammatory effects that underpin exercise, with important subsequent implications for 
health and immunity. The aim of the present study was to characterize changes in the 
expression of PD-1 in circulating naïve, central memory, effector memory and terminally 
differentiated CD8+ T-cells following two time and energy-matched bouts of moderate and 
high intensity cycling. To better understand the link between cellular PD-1 and plasma sPD-1 
/ sPD-L1 in the context of inflammation, sample-matched IL-6 measurements were made.  
 
 
Materials and methods 
Participants 
Following ethical approval from the University of Worcester Research Ethics 
Committee, eight healthy males (mean ± SD: age 29 ± 5 years; BMI 24.2 ± 3.4 kg.m2; O2max 
44.5 ± 6.4 ml·kg-1·min-1) were recruited to take part in the study. All participants completed 
questionnaires addressing health history and habitual levels of weekly physical activity using 
the International Physical Activity Questionnaire (IPAQ). All participants gave their written 
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informed consent and the study was carried out in accordance with the Declaration of 
Helsinki (2008). Participants were non-smokers and reported that they had not taken any 
antioxidant vitamin supplements or anti-inflammatory drugs for 8 weeks prior to the 
laboratory visit. In addition, participants reported to be free from any viral or bacterial 
infections for at least 4 weeks prior to taking part. Participants were also required to refrain 
from any strenuous physical activity, consumption of alcoholic beverages or caffeine for two 
days prior to each experimental session. 
 
Experimental sessions 
Participants reported to the laboratory on three separate occasions, all carried out 
under stable climatic conditions (18 - 20°C and humidity between 45 – 55%). Following a 
thirty-minute period of rest, resting heart rate (RS400, Polar Electro, Finland), height (Seca 
Alpha, Hamburg, Germany) and body mass (Tanita, Tokyo, Japan) were determined on each 
visit. On participants first visit, cardiorespiratory fitness ( max) was assessed using a ramp 
test to exhaustion on an electromagnetically braked cycle ergometer (Lode Excalibur Sport, 
Groningen, Netherlands). Workload commenced at 100 Watts and was increased by 30 Watts 
every 4 minutes. Heart rate and oxygen uptake was assessed continuously using a breath-by-
breath system (Cortex Biophysik Metalyzer, Germany). max was determined if two of the 
following criteria were met in conjunction with a plateau in oxygen consumption after an 
increase in workload: volitional exhaustion; a respiratory exchange ratio of ≥1.15; heart rate 
within 10 beats·min-1 of the age-predicted maximal heart rate (220 - age); a drop in cadence 
below 60 revolutions per minute (Howley et al., 1995). A final obtained value of rate of 
oxygen consumption relative to body mass was accepted as 
 max (ml.kg-1min-1) and used 
to inform the workload for the subsequent two trials. 
At least one week following the max test, participants undertook two energy and 
time-matched cycling trials in a counterbalanced order: a moderate intensity bout of 
continuous cycling at 60% max for 58 minutes (MOD) and a bout of high intensity 
interval exercise (HIIE), consisting of 10 x 4-minute intervals at 85% max, with 2-minute 
rest intervals. Both trials took place following an identical overnight fast at least one week 
apart. In both studies, oxygen uptake was assessed continuously to maintain target  and 
ensure equal energy expenditure between MOD and HIIE. Ratings of perceived exertion 
(RPE) were measured every 6 minutes during the trials. 
2OV&
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Blood sampling 
In both MOD and HIIE, a catheter (Appleton Woods, Birmingham, UK) was inserted 
into the antecubital vein of the arm prior to exercise to obtain a baseline sample after thirty 
minutes of rest (Pre-Ex). Additional blood samples were taken immediately (Post-Ex), 30 
minutes (Post-Ex+30) and 60 minutes (Post-Ex+60) following completion of each cycling 
trial. At Pre and Post+0 timepoints, 18 ml of blood was drawn into two separate vacutainer 
tubes containing potassium ethylene diaminetetraacetic acid (EDTA) (Becton, Dickson & 
Company, Oxford, UK) for independent isolation or peripheral blood monocular cells 
(PBMCs) and plasma. At Post-Ex+30 and Post-Ex+60 timepoints, 9 ml of blood was 
collected for plasma isolation only. The catheter was flushed every 30 minutes with isotonic 
saline solution (0.9% sodium chloride) to prevent blood clotting.  
 
Plasma analyses 
A cytometric bead array technique was used to quantify plasma interleukin (IL)-6 on 
a BD C6 Accuri Flow Cytometer (BD Biosciences, Berkshire). Plasma PD-L1 (BMS2212; 
sensitivity: 0.6 pg/mL, intraassay CV: 2.1%, interassay CV: 3.4%) and PD-1 (BMS2214; 
sensitivity 1.14 pg/mL, intraassay CV: 3.2%, interassay CV: 6.4%) were quantified using 
commercially available ELISA kits (Thermo Fisher Scientific, Loughborough). All 
concentrations were corrected for changes in plasma volume based upon established criteria 
(Dill and Costill, 1974). 
 
Isolation of CD8+ T-cells 
Whole blood from Pre-Ex and Post-Ex timepoints only were used to isolate PBMCs 
using density gradient centrifugation. Blood was diluted 1:1 with Hanks Balance Salt 
Solution (HBSS), and then layered carefully on top of Histopaque 1077 (Sigma, Dorset), 
before centrifuging at 400g for 40 minutes at 21°C.  The PBMC layer was aspirated and then 
washed three times with HBSS, by centrifuging steps at 300g for 10 minutes.  Approximately 
3 million cells per time point were then used to enrich CD8+ T-cells by negative selection 
using MACS® bead separation (Miltenyi Biotec, Surrey, UK). PBMCs were incubated with a 
biotin-antibody cocktail (anti-CD4, CD15, CD16, CD19, CD34, CD36, CD56, CD123, 
TCRγ/δ, and CD235a), followed by a CD8+ T-cell microbead cocktail (anti-CD14, CD61 and 
anti-biotin) for 10 minutes at 4 oC, with intermittent washes using column wash buffer (PBS 
supplemented with 0.5% bovine serum albumin and 2 mM EDTA; pH=7.2). CD8+ cells from 
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both time-points were eluted by negative selection using three separate MiniMACS LD-
column passes, using an excess of de-gassed column buffer (Miltenyi Biotec, Surrey, UK). 
CD8+ T-cell enrichment was confirmed by flow cytometry staining analysing the 
CD3+CD8+ lymphocyte population (>95% purity).  
 
Flow Cytometry 
Approximately 1,000,000 viable PBMCs were used for determination of CD8+ T-cell 
subsets and expression of PD-1 using four-colour flow cytometry (Guava EasyCyte, 
Millipore UK Ltd, Hertfordshire, UK). Cells were incubated with fluorescently conjugated 
antibodies – CD3-FITC (clone: HIT3a), CD279-PE (clone: EH12.2H7), CD45RA-PerCP 
(clone: HI100), CD27-APC (clone: M-T271) (Biolegend, Cambridge, UK) for 30 minutes at 
4°C followed by intermittent washes with PBS for 5 minutes at 300 x g. Compensation was 
adjusted daily by using single stained controls and gates established using fluorescence minus 
one controls. Confirmation of non-specific antibody binding was determined by using 
isotope-matched controls. 
Flow cytometry data were analysed using GuavaSoft 3.1 (Millipore UK Ltd, 
Hertfordshire, UK). Briefly, lymphocytes were gated on forward versus side scatter and 
CD3+ and CD8+ T-cell proportions used to determine MACS enrichment efficacy. MACS 
enriched CD8+ T-cells were identified as naïve (CD27+ CD45RA+), central memory 
(CD27+ CD45RA-), effector memory (CD27- CD45RA-), or terminally differentiated 
effector memory cells (TEMRA: CD27- CD45RA+) accordingly (Di Mitri et al., 2011). Within 
each sub-population, mean fluorescence intensity (MFI) and percentage positive cells was 
established for PD-1 (CD279). The percentage of PD-1+ cells were used with whole blood 
cell counts to determine the circulating number of PD-1+ cells in peripheral blood for each 
sub-population, and adjusted for changes in plasma volume. 
 
Statistical analysis 
The Shapiro Wilk test was used to check for normality in scale data at all time points. 
Variables with a non-normal distribution were log transformed if necessary. Changes in sub-
populations of immune cells, CD8+ cells expressing PD-1, PD-1 expression levels and 
plasma markers (sPD-1, sPD-L1 and IL-6) were assessed over time (Pre, Post, Post-Ex+30 
and Post-Ex+60) and between Trials (MOD, HIIE) by a 2*2 (cellular data) or 2*4 (plasma 
data) repeated-measures analysis of variance (ANOVA) or Wilcoxon Signed Rank Tests, 
depending on variable normality. Post hoc analysis of any ANOVA interaction effects 
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(Trial*Time) were performed by a test of simple effects by pairwise comparisons, with 
Bonferroni correction. Mann Whitney U tests were performed to determine differences 
between MOD and HIIE at different timepoints for non-parametric data. Effect sizes for main 
effects and interaction effects of ANOVA are presented as partial eta2 (η2p), using Cohen’s 
definition of η2p of 0.01, 0.06 and 0.14 for ‘small’, ‘medium’ and ‘large’ effects respectively 
(Cohen, 1988). Pearson correlation and Spearman rank were used to assess the relationship 
between parametric and non-parametric data respectively. All values are presented as means 
± standard deviation or error (indicated throughout manuscript). Data were back transformed 
for ease of presentation in figures. Statistical significance was accepted at the P<0.05 level. 
Statistical analyses were performed using SPSS (PASW Statistics, release 23.0, SPSS Inc., 
Chicago, IL, USA).   
 
Results 
Physiological response during MOD and HIIE 
The physiological responses during each exercise bout are reported in detail 
elsewhere (Wadley et al., 2019). Briefly, Peak 
 
and RPE were significantly greater in 
HIIE compared to MOD (P < 0.00001), but there were no statistically significant differences 
in mean  and energy expenditure.  
 
Changes in lymphocyte sub-populations after MOD and HIIE in blood 
Changes in lymphocyte and CD8+ T-cell subset concentrations are reported in Tables 
1 and 2 respectively. Total lymphocyte concentration increased after both trials (P = 0.014). 
Within the lymphocyte pools, CD3+ (P = 0.011) and CD8+ (P = 0.006) T-cell concentrations 
also increased, with no differences between MOD and HIIE for any lymphocyte subset. 
Within the CD8+ T-cell pool, naïve (P = 0.050), central memory (P = 0.036), effector 
memory (P = 0.050) and TEMRA (P = 0.012) all increased following MOD, but only TEMRA 
increased following HIIE (P = 0.049). There were no statistically significant differences in 
CD8+ T-cell concentrations between MOD and HIIE at any timepoint. 
 
Changes in PD-1+ cell concentration, expression and composition within the CD8+ T-cell 
pool after MOD and HIIE 
 PD-1 expression was significantly higher on central and effector memory T-cell 
subsets when compared to naïve or TEMRA (P’s < 0.0001). The circulating concentration of 
2OV&
2OV&
9 
CD8+ PD-1+ T-cells was significantly higher after both trials (MOD: Z = -2.38, P = 0.017, η2 
= 0.35 and HIIE: Z = -1.26, P = 0.234), however there were no significant differences 
between trials (Z = -2.10, P = 0.035, η2 = 0.28). Changes in PD-1+ cell concentration and 
expression within CD8+ T-cell subsets are reported in Figures 1 and 2 respectively. Within 
the CD8+ T-cell pool, there was a significant increase in PD-1+ central memory cells 
following HIIE only (Z = -2.31, P = 0.021, η2 = 0.33), with cell number significantly higher 
than MOD Post-Ex (Z = -2.52, P = 0.010. η2 = 0.40). In addition, PD-1 MFI was significantly 
greater in central memory cells following HIIE, indicating an increase in receptor expression 
(Z = -2.24, P = 0.025, η2 = 0.31).  
 
Changes in sPD-1, sPD-L1 and IL-6 in response to MOD and HIIE and associations with 
cellular variables 
 Changes in plasma levels of sPD-1 and sPD-L1 are reported in Figure 3. sPD-L1 
concentration increased immediately (MOD: Z = -2.38, P = 0.017, η2 = 0.35 and HIIE: Z = -
2.38, P = 0.017, η2 = 0.35) after exercise and was elevated Post-Ex+30 and Post-Ex+60 
(MOD: Z = -2.52, P = 0.012, η2 = 0.40 and HIIE: Z = -2.52, P = 0.012, η2 = 0.40). A decrease 
in sPD-1 concentration was observed immediately after both trials (MOD: Z = -2.52, P = 
0.012, η2 = 0.40 and HIIE: Z = -2.24, P = 0.025, η2 = 0.31), and remained below Pre-Ex levels 
at Post-Ex+60 (MOD: Z = -2.38, P = 0.017, η2 = 0.35 and HIIE: Z = -2.10, P = 0.036, η2 = 
0.28). IL-6 concentration increased above Pre-Ex at all post-exercise timepoints in both trials 
(Time effect: F (3) = 15.5, P < 0.0001, η2 = 0.66), with the magnitude of increase 
significantly greater following HIIE (Time x Condition effect: F (3) = 7.0, P < 0.001, η2 = 
0.47). A positive correlation was noted between concentrations of IL-6 and PD-L1 Post-Ex (r 
= 0.57; P = 0.021). No statistically significant correlations were noted between plasma and 
cellular variables. 
 
 
Discussion 
The current study highlights that single bouts of moderate and high intensity interval 
exercise evoke an increase in the circulating concentration of PD-1+ CD8+ T-cells in young, 
untrained, healthy males. As part of this response, the number of PD-1+ CD8+ central 
memory T-cells increased following HIIE only, with PD-1 expression also increased on these 
cells. Plasma sPD-L1 and sPD-1 increased and decreased respectively after both trials, with a 
positive association noted between IL-6 and PD-L1. Taken together, these results highlight a 
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phenotypic specific change in the regulation of PD-1 on CD8+ T-cells that is exercise 
intensity-dependent. Furthermore, we highlight for the first time that soluble forms of the PD-
1 receptor and ligand are reciprocally regulated after exercise, and relate to changes in IL-6. 
This study provides evidence of a potentially novel aspect of the anti-inflammatory response 
to exercise and warrants further investigation to contextualise the findings amongst other 
established mechanisms. 
A single session of exercise induces large haemodynamic and β2-adrenergic receptor-
mediated changes that drive the mobilisation of lymphocytes into the bloodstream (Graff et 
al., 2018). This response is not uniform, with lymphocytes such as CD8+ T-cells with high 
antigen specificity, activation and migratory capacity being preferentially mobilised (e.g. 
effector T-cells) (Campbell et al., 2009). The general consensus is that this response is highly 
functional, and operates to enhance immunosurveillance and tissue remodelling in the period 
after exercise (Campbell and Turner, 2018). As a result, exercise immunology research has 
largely focussed on characterising CD8+ T-cells with regards to their activation, migration 
and effector functions (e.g. cytotoxicity). Conversely, relatively little attention has been paid 
to negative regulators of T-cell function, which might act to suppress or modulate this 
functional redistribution of T-cells. The results of the current study demonstrate that both 
MOD and HIIE evoke an increase in PD-1+ CD8+ T-cell concentration into the bloodstream. 
The magnitude of this response was comparable between trials; however, the phenotypic 
responses differed, with the concentration of central memory CD8+ T-cells expressing PD-1 
(Figure 1) and the surface expression level (MFI) on these cells increasing after HIIE only 
(Figure 2). Coupled to the finding that CD8+ PD-1- central memory T-cells were not 
significantly elevated after HIIE (data not shown), this indicates a specific phenotypic change 
with regards to PD-1 regulation within the central memory T-cell pool, rather than just 
changes in T-cell trafficking into the periphery.  
PD-1 is a critical regulator of T-cell tolerance, modulating changes in cell 
activation (Keir et al., 2007), differentiation (Ahn et al., 2018) and migration into 
tissues (Brunner-Weinzierl and Rudd, 2018). Expression of PD-1 is primarily limited 
to memory T-cells (Gustafson et al., 2017) (Figure 2), with progressive loss of the PD-
1 receptor documented on T-cells with higher effector functions, such as TEMRA, which 
are typically the most sensitive to exercise-induced mobilisation (Campbell et al., 
2009). Whereas effector memory T-cells circulate between blood and peripheral tissues, 
central memory T-cells circulate between lymph and blood (Drouillard et al., 2018), awaiting 
antigen presentation. We speculate that an increase in CD8+ central memory T-cell PD-1 
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expression after HIIE may be a homeostatic mechanism to limit T-cell receptor activation, 
differentiation and redistribution of antigen-specific T-cells from the lymphatic system after 
exercise. This change is directly related to the intensity of exercise, given that the HIIE 
protocol controlled for both total exercise duration and the energy cost of exercise, compared 
to MOD.  
The only previous study to investigate changes in immune checkpoint expression after 
exercise reported an increase in the percentage of PD-1+, but not CTLA-4+ CD8+ T-cells 
after maximal cycling exercise (Gustafson et al., 2017). A compositional increase in PD-1+ 
CD8+ T-cells was not observed in the present study, and as such, suggests that preferential 
trafficking of PD-1+ CD8+ T-cells may only increase in response to maximal cycling 
exercise. Notably however, the current study subsequently phenotyped CD8+ T-cells, as well 
as determining physiologically relevant changes within the bloodstream in response to 
exercise. Importantly, the increase in CD8+ PD-1+ central memory T-cells composed a very 
small component of the total exercise-induced lymphocytosis (Pre-Ex: 0.38% to Post-Ex: 
0.69%). Our data therefore provide novel insight into changes in PD-1 within T-cells after 
different intensities of exercise, both with regards to cell phenotype and physiologically 
relevant changes within the circulation. Both are undoubtedly important in understanding 
changes in T-cell function and their redistribution after exercise. Future work should take this 
approach to establish whether a small increase in CD8+ PD-1+ central memory T-cells has 
physiological relevance in governing the immune responses to exercise. For a more complete 
picture, other immune checkpoints, such as CTLA-4 should be explored in this context. 
Another novel finding from the present study was that exercise evoked an increase in 
the circulating plasma concentration of sPD-L1 and decrease in sPD-1 immediately, and up to 
60 minutes post-exercise (Figure 3). These responses were not dependent on the intensity of 
exercise, nor associated with changes in membrane-bound PD-1 expression or circulating 
PD-1+ cell numbers. The exact cellular origin and functional actions of these soluble immune 
checkpoints have yet to be fully established. Both sPD-1 (primarily released from T-cells) 
and sPD-L1 (released from dendritic cells and tissues) (Gu et al., 2018) can be produced 
through alternate mRNA splicing (Nielsen et al., 2005) or cleavage of the membrane-bound 
form directly (Zanto et al., 2011). There is some evidence to suggest that sPD-1 and sPD-L1 
may act in an antagonistic manner, such that sPD-1 competes and sPD-L1 engages with 
membrane-bound PD-1 (Gu et al., 2018; He et al., 2005). This is supported by studies 
suggesting that sPD-1 enhances (Yuan et al., 2004) and sPD-L1 inhibits (Li et al., 2016) T-
cell activity. From the current study, we can therefore speculate that an increase in sPD-L1 
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after exercise may form a component of the anti-inflammatory response to exercise, acting to 
engage and activate membrane-bound PD-1. This is supported by a reduction in sPD-1 
concentration and a positive association between post-exercise sPD-L1 and IL-6 (Figure 4), a 
pleiotropic cytokine with a role in anti-inflammatory signalling (Ellingsgaard et al., 2019). It 
must be noted that the cellular mechanisms mediating the removal of sPD-1 from the 
circulation in this short timeframe after exercise is far from clear at present. Further work is 
needed to fully understand the kinetics of soluble immune checkpoints after exercise and 
their functional role is regulating communication between immune cells and tissues. 
PD-1 and other immune checkpoints have attracted significant attention in biomedical 
and clinical research because of their profound impact on regulating immune tolerance in 
diseases associated with immune dysfunction. Immune checkpoint expression is commonly 
elevated on T-cells isolated from patients with blood and tissue cancers (Ilie et al., 2016; Lu 
et al., 2017; Novák et al., 2015) and conversely reduced on T-cells from patients with various 
autoimmune diseases (Bartosińska et al., 2018; Granados et al., 2017; Iijima et al., 2017; 
Li et al., 2014). How an increase in PD-1 expression after acute exercise translates into 
changes with regular exercise training, particularly in these populations is currently unknown. 
It is conceivable that exercise-induced upregulation of PD-1 expression could enhance 
immune tolerance in patients with certain autoimmune diseases; however, more work is 
needed to investigate the effects of regular exercise on immune checkpoints in a clinical 
context.  
 
Conclusion 
The results of the current study have highlighted phenotypic and physiological 
relevant changes in PD-1+ CD8+ T-cells after bouts of MOD and HIIE. PD-1+ CD8+ T-cells 
are mobilised in response to both types of exercise, however, central memory CD8+ T-cells 
expressing PD-1 increased after HIIE only. Despite this being a very small component of the 
exercise-induced lymphocytosis, PD-1 expression also increased on these cells, highlighting a 
specific phenotypic response associated with exercise at higher intensities. We have also 
highlighted for the first time that soluble immune checkpoints are altered in response to 
exercise, with sPD-L1 and sPD-1 increasing and decreasing up to 60 minutes after exercise 
respectively. Further work is needed to examine the changes in membrane and soluble 
immune checkpoints after exercise, and their relevance to regulating health in the context of 
autoimmunity. 
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Table Legends 
 
Table 1: Mean changes (SD) in total lymphocytes, CD3+ and CD8+ T-cells before and after 
MOD and HIIE. 
 
Table 2: Mean changes (SD) in CD8+ T-cell subsets before and after MOD and HIIE. 
 
 
Figure Legends 
 
Figure 1: Changes in the concentrations of CD8+ T-cell subsets (naïve, central memory, 
effector memory and terminally differentiated effector memory (TEMRA) cells) before (black 
bars) and after (white bars) MOD (panel A) and HIIE (panel B). Values are means ± standard 
error. * indicates significant differences relative to Pre-Ex: * p<.05. + indicates a significant 
difference between MOD and HIIE: + p<.05. 
 
Figure 2: Changes in the expression of PD-1 in CD8+ T-cells and their subsets before (black 
bars) and after (white bars) MOD (panel A) and HIIE (panel B). Values are means ± standard 
error. * indicates a significant difference relative to Pre-Ex: * p<.05. # indicates significantly 
higher expression levels in memory T-cells subsets, compared to naïve and TEMRA: ### 
p<.0001 
 
Figure 3: Changes in the concentrations of PD-L1 (A) and PD-1 (B) before (Pre-Ex) and 
after (Post-Ex, Post-Ex+30 and Post-Ex+60) MOD (grey bars) and HIIE (white bars). Values 
are means ± standard error. * indicates a significant difference relative to Pre-Ex: * p<.05. # 
indicates a significant difference relative to Post-Ex: # p<.05.  
 
Figure 4: Pearson’s correlation between Post-Ex IL-6 and sPD-L1 concentrations across both 
trials (n=16). 
Table 1. Mean changes (SD) in total lymphocytes, CD3+ and CD8+ T-cells before and after MOD and HIIE. 
 
 
 
 
 
 
 
 
 
 
Legend: *P < 0.05; NS P > 0.05 
 
 
 
 
 
 
 
 
 
 Pre-Exercise Post-Exercise Main Effects of Time Time x Trial Interaction 
Lymphocytes (cells/ uL)  
MOD 1720.2 (651.1) 2761.3 (1292.3) * 
F (1,7) = 10.7; P = 0.014; η2 = 0.6 F (1,7) = 0.03; P = NS 
HIIE 1559.4 (456.9) 2523.7 (1165.7) * 
CD3+ T-cells (cells/ uL)  
MOD 1272.8 (515.1) 2022.19 (515.1) * 
F (1,7) = 11.7; P = 0.011; η2 = 0.6 F (1,7) = 0.02; P = NS 
HIIE 1180.9 (365.9) 1877.2 (870.9) * 
CD8+ T-cells (cells/ uL)  
MOD 419.5 (161.2) 717.8 (337.4) * 
F (1,7) = 15.1; P = 0.006; η2 = 0.7 F (1,7) = 0.22; P = NS 
HIIE 413.0 (101.7) 688.9 (310.6) * 
 
 Table 2. Mean changes (SD) in CD8+ T-cell subsets before and after MOD and HIIE. 
Naïve CD8+ T-cells (cells/ uL) 
 Pre-Ex Post-Ex Time: Pre vs. Post 
MOD 84.8 (120.3) 161.7 (209.8) * Z = -1.96; P = 0.05, η2 = 0.24 
HIIE 81.0 (63.1) 116.8 (82.8) Z = -1.12; P = NS 
Trial: MOD vs HIIE Z = -0.42; P = NS Z = 0; P = NS  
Central Memory CD8+ T-cells (cells/ uL) 
 Pre-Ex Post-Ex Time: Pre vs. Post 
MOD 50.3 (46.2) 126.0 (142.1) * Z = -2.10; P = 0.036, η2 = 0.28 
HIIE 89.9 (75.8) 159.8 (158.6) Z = -1.26; P = NS 
Trial: MOD vs HIIE Z = -1.05; P = NS Z = -0.84; P = NS  
Effector Memory CD8+ T-cells (cells/ uL) 
 Pre-Ex Post-Ex Time: Pre vs. Post 
MOD 113.1 (72.5) 166.9 (59.0) * Z = -1.96 P = 0.05, η2 = 0.24 
HIIE 123.6 (96.1) 168.0 (127.0) Z = -1.12; P = NS 
Trial: MOD vs HIIE Z = 0; P = NS Z = -0.63; P = NS  
Terminally Differentiated Effector Memory CD8+ T-cells (cells/ uL) 
 Pre-Ex Post-Ex Time: Pre vs. Post 
MOD 171.3 (65.4) 263.2 (94.1) * Z = -2.52; P = 0.012, η2 = 0.40 
HIIE 118.4 (98.1) 244.3 (184.5) * Z = -1.82; P = 0.049, η2 = 0.21 
Trial: MOD vs HIIE Z = -1.26; P = NS Z = -0.84; P = NS  
 
Legend: *P < 0.05; NS P > 0.05 
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Figure 3:  Wadley et al, 2019
0
10
20
30
40
50
60
70
s
P
D
-
1
 
(
p
g
/
m
L
)
0
5
10
15
20
25
s
P
D
-
L
1
 
(
p
g
/
m
L
)
*
*
*
*
*
*
* * *
*
*
#
A
B
Figure 4:  Wadley et al, 2019
0
5
10
15
20
25
30
0 2 4 6 8 10
P
D
-
L
1
 
(
p
g
/
m
l
)
IL-6 (pg/ml)
r = 0.57
P = 0.021 
Highlights  
• PD-1 is a membrane-bound T-cell receptor that regulates immune tolerance 
• We explored phenotypic changes in PD-1+ T-cells after exercise 
• Circulating PD-1+ CD8+ T-cells increased after moderate and high intensity interval 
exercise (HIIE) 
• Central memory CD8+ T-cell number and expression increased after HIIE only  
• Post-exercise levels of soluble PD-1 Ligand increased and correlated with IL-6 
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